Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genflow Biosci (GENF) Share Price

Price 1.025p on 18-04-2025 at 04:45:10
Change 0.00p 0%
Buy 1.05p
Sell 1.00p
Buy / Sell GENF Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 88,475.00 at 1.01556p
Day's Volume: 0
Last Close: 1.025p
Open: 0.00p
ISIN: GB00BP2C3V08
Day's Range 0.00p - 0.00p
52wk Range: 0.98p - 3.30p
Market Capitalisation: £4m
VWAP: 0.00p
Shares in Issue: 391m

Sector: Medicine and Biotech

Genflow Biosci (GENF) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 88,475 1.01556p Ordinary
 16:28:40 - 17-Apr-25
Unknown* 1,500,000 1.02p Negotiated Trade
 16:22:41 - 17-Apr-25
Unknown* 1,000,000 1.0474p Ordinary
 16:21:38 - 17-Apr-25
Buy* 241,441 1.0474p Ordinary
 16:21:08 - 17-Apr-25
Buy* 500,000 1.0474p Ordinary
 16:19:58 - 17-Apr-25
Unknown* 1,500,000 1.00p Negotiated Trade
 16:13:40 - 17-Apr-25
Buy* 201,961 1.0334p Ordinary
 16:13:16 - 17-Apr-25
Buy* 250,000 1.05p Ordinary
 16:10:47 - 17-Apr-25
Unknown* 1,000,000 1.0334p Ordinary
 16:08:35 - 17-Apr-25
Unknown* 1,000,000 1.00p Ordinary
 16:08:05 - 17-Apr-25
See more Genflow Biosci trades

Genflow Biosci (GENF) Share Price History

Time period:
to
Date Open High Low Close Volume
18th Apr 2025 (Fri) 1.025 1.025 1.025 1.025 0
17th Apr 2025 (Thu) 1.025 1.025 1.025 1.025 12,668,401
16th Apr 2025 (Wed) 1.05 1.05 1.025 1.025 2,554,464
15th Apr 2025 (Tue) 1.10 1.05 1.05 1.05 2,325,640
14th Apr 2025 (Mon) 1.05 1.15 1.10 1.10 8,340,038
11th Apr 2025 (Fri) 1.00 1.05 1.00 1.05 556,824
10th Apr 2025 (Thu) 1.05 0.98 0.98 0.98 522,754
9th Apr 2025 (Wed) 1.00 1.00 0.98 1.00 453,695
8th Apr 2025 (Tue) 1.00 1.00 1.00 1.00 745,107
7th Apr 2025 (Mon) 1.025 1.025 1.00 1.00 1,024,181
4th Apr 2025 (Fri) 1.025 1.025 1.00 1.025 1,063,039
3rd Apr 2025 (Thu) 1.075 1.07 1.07 1.07 1,411,413
2nd Apr 2025 (Wed) 1.075 1.10 1.075 1.10 749,285
1st Apr 2025 (Tue) 1.15 1.10 1.075 1.075 1,253,471
31st Mar 2025 (Mon) 1.15 1.175 1.15 1.15 920,840
28th Mar 2025 (Fri) 1.15 1.18 1.15 1.15 4,389,375
27th Mar 2025 (Thu) 1.20 1.18 1.10 1.18 9,017,182
26th Mar 2025 (Wed) 1.23 1.30 1.20 1.20 5,808,140
25th Mar 2025 (Tue) 1.40 1.50 1.45 1.45 8,402,570
24th Mar 2025 (Mon) 1.40 1.43 1.40 1.40 406,680
21st Mar 2025 (Fri) 1.45 1.45 1.40 1.40 603,462
20th Mar 2025 (Thu) 1.55 1.525 1.45 1.45 4,818,904
19th Mar 2025 (Wed) 1.55 1.60 1.55 1.55 1,005,654
See more Genflow Biosci price history

Genflow Biosci (GENF) Regulatory News

Date Source Headline
14th Apr 2025 7:00 am RNS-R Launch of AI-Powered Partnership
10th Apr 2025 7:00 am RNS-R Genflow Launches New Development Program
28th Mar 2025 7:10 am RNS Holding in Company
28th Mar 2025 7:00 am RNS Director Dealings
26th Mar 2025 7:00 am RNS Institutional Investment
20th Feb 2025 7:00 am RNS-R Advancements in SIRT6 Variant Patent Application
13th Jan 2025 7:30 am RNS Holding(s) in Company
13th Jan 2025 7:00 am RNS Holding(s) in Company
6th Jan 2025 7:00 am RNS-R 2024 Highlights
22nd Oct 2024 7:00 am RNS Genflow Secures Non-Dilutive Financial Support
See more Genflow Biosci regulatory news

Genflow Biosci (GENF) Share News

IN BRIEF: Genflow launches new ophthalmology development programme

10th Apr 2025 14:24

Genflow Biosciences PLC - London-based biotechnology firm, which has research facilities in Belgium - Launches new ophthalmology development programme, focused on advancing a novel gene therapy via its proprietary gene technology. The therapy will use a specially designed non-viral vector engineered for precise delivery of Genflow's SIRT6 to the eye. It is designed to counter ocular problems including several pathologies of the cornea and glaucoma. Read More

Genflow Biosciences enters 2025 with confidence in research progress

6th Jan 2025 14:28

(Alliance News) - Genflow Biosciences PLC on Monday saw shares climb after reporting "significant strides" in its 2024 research programmes. Read More

Genflow Biosciences secures EUR4 million for liver disease treatment

22nd Oct 2024 11:49

(Alliance News) - Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, to support its gene therapy development work. Read More

EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens

27th Jun 2024 20:23

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2024 15:48

Read More

See more Genflow Biosci news
FTSE 100 Latest
Value8,275.66
Change0.00

Login to your account

Forgot Password?

Not Registered